Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P38
Within normal range
Streak
2 qtr
Consecutive declineStable
Average
-453.29%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 7.14% |
| Q2 2025 | 90.28% |
| Q1 2025 | -17242.86% |
| Q4 2024 | 103.82% |
| Q3 2024 | 65.63% |
| Q2 2024 | -120.69% |
| Q1 2024 | 6.45% |
| Q4 2023 | -19.23% |
| Q3 2023 | 7.14% |
| Q2 2023 | 17.65% |
| Q1 2023 | 2.86% |
| Q4 2022 | 5.41% |
| Q3 2022 | -15.62% |
| Q2 2022 | 15.79% |
| Q1 2022 | -18.75% |
| Q4 2021 | -500.00% |
| Q3 2021 | 138.10% |
| Q2 2021 | 53.33% |
| Q1 2021 | -212.50% |
| Q4 2020 | 385.71% |
| Q3 2020 | 6.67% |
| Q2 2020 | -1600.00% |
| Q1 2020 | 1766.67% |
| Q4 2019 | 99.68% |
| Q3 2019 | -18.75% |
| Q2 2019 | 20.00% |
| Q1 2019 | 4.76% |
| Q4 2018 | -10.53% |
| Q3 2018 | -11.76% |
| Q2 2018 | 15.00% |
| Q1 2018 | -11.11% |
| Q4 2017 | 5.26% |
| Q3 2017 | 26.92% |
| Q2 2017 | 0.00% |
| Q1 2017 | -23.81% |
| Q4 2016 | -10.53% |
| Q3 2016 | 9.52% |
| Q2 2016 | 8.70% |
| Q1 2016 | -1177.78% |